Coagulation Products

Coagulation products used to manage bleeding in patients with these disorders include AHF concentrates, factor IX concentrates, factor VIIa concentrate, factor IX complexes, anti-inhibitor coagulant complexes, and desmopressin acetate. Discover the latest research on coagulation products here.

July 8, 2020

Comparative proteomic profiling and functional characterization of venom pooled from captive crotalus durissus terrificus specimens and the Brazilian crotalic reference venom

Toxicon : Official Journal of the International Society on Toxinology
Lidia J TasimaAnita M Tanaka-Azevedo
July 9, 2020
Open Access

The traceability of commercial plasma calibrators to the plasma International Standards for factor VIII and factor IX

International Journal of Laboratory Hematology
Helen V WilmotElaine Gray
July 12, 2020
Review

Cardiac Troponin for the Diagnosis and Risk-Stratification of Myocardial Injury in COVID-19: JACC Review Topic of the Week

Journal of the American College of Cardiology
Yader SandovalAllan S Jaffe
July 10, 2020
Open Access

PARAFAC model as an innovative tool for monitoring natural organic matter removal in water treatment plants

Water Science and Technology : a Journal of the International Association on Water Pollution Research
Sikelelwa N NdiweniThabo T I Nkambule
July 7, 2020

Expression of tissue factor mRNA in thrombosis associated with antiphospholipid syndrome

Journal of Thrombosis and Thrombolysis
Bruna de Moraes MazettoFernanda Andrade Orsi
July 7, 2020

Successful treatment by switching from activated prothrombin complex concentrate to emicizumab therapy in a hemophilia A patient with inhibitors

[Rinshō ketsueki] The Japanese journal of clinical hematology
Atsushi SakamotoAkira Ishiguro
July 12, 2020
Case Report

Acquired von Willebrand syndrome secondary to mitral and aortic regurgitation

Journal of Cardiac Surgery
Mio KasaiMichiko Aoki
July 9, 2020
Review

Hemophilia gene therapy-New country initiatives

Haemophilia : the Official Journal of the World Federation of Hemophilia
Ulrike M ReissTsukasa Ohmori
July 11, 2020
Review

Experience of Immune Tolerance Induction Therapy for Hemophilia A Patients with Inhibitors from a Single Center in India

Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
Tulika Seth
July 7, 2020

Small procoagulant platelets in diabetes type 2

Thrombosis Research
Maria EdvardssonPetter Järemo
July 3, 2020

Acute kidney injury in decompensated cirrhosis is associated with both hypo- and hyper-coagulable features

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Alberto ZanettoGuadalupe Garcia-Tsao
July 3, 2020
Open Access

Silent NK/T cell reactions to dasatinib during sustained deep molecular response before cessation are associated with longer treatment-free remission

Cancer Science
Takashi KumagaiKanto CML, Shimousa Hematology Study Groups
July 7, 2020
Open Access

A previously treated severe haemophilia A patient developed high-titre inhibitor after vaccinations

International Journal of Immunopathology and Pharmacology
Zekun LiRunhui Wu
July 7, 2020
Open Access

Inhibitor development in previously untreated patients with severe haemophilia: A comparison of included patients and outcomes between a clinical study and a registry-based study

Haemophilia : the Official Journal of the World Federation of Hemophilia
Carla J JonkerH Marijke van den Berg

Sign up to follow this feed and discover related papers.

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.

Immuno-Oncology

Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.

Immunomodulating Agents

Immunomodulating agents are substances that stimulate or suppresse the immune system and may help the body combat againsts cancer, infection, or other diseases. Discover the latest research on immunomodulating agents here.

Metastatic Malignancy Treatments

Treatment of metastatic cancers depends on the type of cancer and the severity of the disease. The regime often includes medications such as chemotherapy or hormone therapy, but may also include immunotherapy, radiation therapy, surgery or a combination. Discover the latest research on metastatic cancer treatments here.

Pharmacological Treatment of Allergies

Allergies, also known as allergic diseases, are a number of conditions caused by hypersensitivity of the immune system to typically harmless substances in the environment. There are various pharmacological treatments for allergy including antihistamines, anti-cholinergics, decongestants, etc. Discover the latest research on pharmacological treatment of allergies here.

Platelet Drugs and Antocoagulants

Antiplatelet drugs decrease platelet aggregation and inhibit thrombus formation while anticoagulants are blood thinners that prolong clotting time. Both agents are amongst the most commonly used medications to reduce coagulation.

© 2020 Meta ULC. All rights reserved
/feed-previews/coagulation-products/af4431f3-aa82-4e67-bf34-7fd19e4c8331